Clinical trial proves positive for diabetes drug by Sangamo BioSciences

On the basis of the clinical trial, Sangamo BioSciences Inc. is been successful in making the diabetes drug helping the problem of blocked nerves in lower limbs.

The company has come to the conclusion after the interim data from a mid-stage test of Sangamo’s drug SB-509.

Another test of Sangamo’s (NASDAQ: SGMO) drug using a separate measure of its ability to help diabetics regain nerve sensitivity also showed positive results, the Richmond company said.

Source: East Bay Business Times

Filed under Diabetes, Diabetes Drug | Tags: , , | Comment Below


Leave a Reply

Protected by Comment Guard Pro